{
  "scenario_id": "healthcare_telemedicine_platform_scalability_decision",
  "context": "Major healthcare system evaluating expansion of AI-enhanced telemedicine platform to serve underserved populations across multiple states with advanced diagnostic capabilities",
  "stakeholders": {
    "requester": "Chief Medical Officer",
    "approvers": ["CEO", "CFO", "Chief Information Officer", "Chief AI Officer"],
    "influencers": ["Patient Services Director", "IT Director", "Regulatory Compliance Officer", "AI Ethics Board", "State Medical Boards"]
  },
  "request": {
    "amount": "$9.5M",
    "purpose": "Scale AI-enhanced telemedicine platform to support 750,000 annual virtual consultations with advanced diagnostic AI across 20 states",
    "urgency": "high",
    "justification": "Address healthcare access gaps in rural areas, reduce patient travel costs by 60%, improve health outcomes through AI-assisted preventive care"
  },
  "decision_process": [
    {
      "stage": "advanced_feasibility_assessment",
      "duration": "5 weeks",
      "activities": ["AI technology capability evaluation", "Advanced regulatory landscape analysis", "AI ethics impact assessment", "Enhanced financial modeling"],
      "outcome": "Confirmed AI-enhanced feasibility with advanced clinical benefits"
    },
    {
      "stage": "stakeholder_engagement",
      "duration": "4 weeks",
      "activities": ["Provider AI training assessment", "Patient acceptance surveys for AI diagnostics", "State regulatory consultations on AI", "AI ethics board review"],
      "outcome": "Strong support for AI-enhanced platform with comprehensive training requirements identified"
    },
    {
      "stage": "financial_evaluation",
      "duration": "3 weeks",
      "activities": ["AI-enhanced ROI analysis", "Advanced reimbursement modeling", "AI cost-benefit analysis", "Risk assessment with AI factors"],
      "outcome": "Positive ROI projected with 2.5-year payback period including AI development costs"
    },
    {
      "stage": "executive_review",
      "duration": "2 weeks",
      "activities": ["Executive committee presentation with AI demonstrations", "Board discussion on AI ethics", "Final approval process", "AI governance framework establishment"],
      "outcome": "Approved with AI governance framework and enhanced implementation plan"
    }
  ],
  "business_impact": {
    "expected_outcome": "Improved healthcare access for 750,000 patients annually, 35% reduction in emergency visits through AI diagnostics, $75M annual cost savings",
    "projected_value": "$200M in improved health outcomes and AI-driven cost savings over 5 years",
    "risk_factors": ["AI diagnostic accuracy validation", "Advanced regulatory changes in telemedicine AI", "Technology integration challenges with AI", "Provider adoption resistance to AI tools", "AI ethics and bias concerns"]
  },
  "decision_criteria": ["AI-enhanced clinical effectiveness and patient outcomes", "Advanced financial sustainability and AI ROI", "Regulatory compliance across jurisdictions for AI", "Technical feasibility and AI scalability", "Stakeholder acceptance and AI adoption"],
  "outcome": "Approved",
  "lessons_learned": "AI integration requires comprehensive ethics review and governance, early stakeholder engagement critical for AI adoption, enhanced training essential for AI-assisted diagnostics, phased implementation reduces AI integration risks"
}